All of these aspects also highlighted the possibility of searching for synaptic biomarkers in the CSF of AD patients, a research line that led to encouraging results, such as the identification of higher levels of SNAP-25 and SYT1 in the CSF of AD and prodromal AD cases [82,83]. Here, SYT1 is linked to Alzheimer disease.